En Es
Productos
Covid-19
Compañías
Segunda mano
Noticias
Eventos
Acerca de nosotros:       ¡Únase ahora!
Categorías

Ver productos por categoría

Cuidados intensivos

Medicina de emergencia

Cuidados intensivos

Cuidado respiratorio

Sistemas de Anestesiología

Cuidados domiciliarios

Rehabilitación

Otro

Infraestructura hospitalaria

Equipamiento TI

Sistemas de Transporte

Gestión de residuos

Otro

Imágenes medicas

Tomografía computarizada

Radiografía Digital

Sistemas de gestión de imágenes

Radiología intervencionista

Imágenes por resonancia magnética

Mamografía

PACS / RIS

Tomografía de emisión de positrones

Seguridad de las radiaciones

Radiografía

Tomografía computarizada de emisión de fotón único

Ultrasonido

Otro

Atención al paciente

Cuidado bariátrico

Camas

Equipos de examen

Otro

Cirugía

Endoscopia

Laparoscopia

Cirugía laser

Equipamiento de quirófano

Esterilización

Implantes quirúrgicos

Instrumentos quirúrgicos

Gestión de residuos

Otro

Expo: Laboratorio clínico

Analizadores de Sangre y Gas

Contadores de Células

Centrífugas

Analizador de Química Clínica

Analizadores de Coagulación

Laboratorio General

Analizadores de Hematología

Sistemas de Inmunoensayo

Cristalería de Laboratorio

Lector de Microplacas

Microscopios

Pipetas

Pruebas Rápidas

Kits para Análisis Listos para Usar

Analizador de Orina

Pruebas Punto de Atención

Ver productos por categoría

Cerrar

Avacta Life Sciences Ltd.

Avacta Life Sciences Ltd.

Avacta Life Sciences Ltd. is a biotechnology company that develops safe and efficacious drugs, and high performing diagnostics based on its proprietary Affimer® and pre|CISION™ platforms. Avacta’s therapeutics division develops novel cancer immunotherapies and its diagnostics division develops high performing diagnostic ...
Productos Covid-19Resumen
Close

Covid-19 Avacta Life Sciences Ltd.

Laboratorio clínico

SARS-CoV-2 Antigen Lateral Flow Test
AffiDX SARS-CoV-2 Antigen Lateral Flow Test

The Avacta AffiDX SARS-CoV-2 Antigen Lateral Flow Test is a qualitative in vitro diagnostic (IVD) test to detect SARS-CoV-2 antigen in human anterior nasal swabs. It is an ideal solution for point-of-care and decentralized testing to identify individuals with higher viral loads of SARS-CoV-2 that increase the likelihood of transmitting the infection to others. The test is wholly developed and manufactured in the UK utilizing accurate, flexible Affimer technology, and validated against emerging variants of SARS-CoV-2.
Mas detalles
Close

Sobre Avacta Life Sciences Ltd.

Avacta Life Sciences Ltd. is a biotechnology company that develops safe and efficacious drugs, and high performing diagnostics based on its proprietary Affimer® and pre|CISION™ platforms. Avacta’s therapeutics division develops novel cancer immunotherapies and its diagnostics division develops high performing diagnostics as well as works with partners world-wide to develop Affimer reagents.

Actualizado

Reagents
Affimer Reagents in Affinity Purification

Affimer technology offers unique solutions in the field of affinity purification through the ability to develop highly specific and stable capture reagents for a wide-range of novel targets. The robust nature of Affimer reagents allows them to withstand industrial cleaning-in-place conditions without significant leaching, while highly reproducible manufacturing assures the consistency of supply. Affimer reagents can be engineered to orient the binder on the resin to optimize target binding. Implementing Affimer reagents in affinity chromatography and bioprocessing applications opens up the potential of unmet needs in this field.
Mas detalles

Immunoassay Reagents
Affimer Immunoassay Reagents

Affimer reagents have been successfully used to detect and quantify antigens across a broad range of immunoassay platforms. Highly specific Affimer binders can be generated to a wide variety of novel targets and routinely show minimal matrix effects within the assay environment. The application of these binders as capture reagents within an immunoassay can increase the potential specificity and dynamic range of the assay, delivering improved accuracy and the opportunity to multiplex sample analysis.
Mas detalles

SARS-CoV-2 Antigen Lateral Flow Test
AffiDX SARS-CoV-2 Antigen Lateral Flow Test

The Avacta AffiDX SARS-CoV-2 Antigen Lateral Flow Test is a qualitative in vitro diagnostic (IVD) test to detect SARS-CoV-2 antigen in human anterior nasal swabs. It is an ideal solution for point-of-care and decentralized testing to identify individuals with higher viral loads of SARS-CoV-2 that increase the likelihood of transmitting the infection to others. The test is wholly developed and manufactured in the UK utilizing accurate, flexible Affimer technology, and validated against emerging variants of SARS-CoV-2.
Mas detalles

Laboratorio clínico

Reagents
Affimer Reagents in Affinity Purification

Affimer technology offers unique solutions in the field of affinity purification through the ability to develop highly specific and stable capture reagents for a wide-range of novel targets. The robust nature of Affimer reagents allows them to withstand industrial cleaning-in-place conditions without significant leaching, while highly reproducible manufacturing assures the consistency of supply. Affimer reagents can be engineered to orient the binder on the resin to optimize target binding. Implementing Affimer reagents in affinity chromatography and bioprocessing applications opens up the potential of unmet needs in this field.
Mas detalles

Immunoassay Reagents
Affimer Immunoassay Reagents

Affimer reagents have been successfully used to detect and quantify antigens across a broad range of immunoassay platforms. Highly specific Affimer binders can be generated to a wide variety of novel targets and routinely show minimal matrix effects within the assay environment. The application of these binders as capture reagents within an immunoassay can increase the potential specificity and dynamic range of the assay, delivering improved accuracy and the opportunity to multiplex sample analysis.
Mas detalles

SARS-CoV-2 Antigen Lateral Flow Test
AffiDX SARS-CoV-2 Antigen Lateral Flow Test

The Avacta AffiDX SARS-CoV-2 Antigen Lateral Flow Test is a qualitative in vitro diagnostic (IVD) test to detect SARS-CoV-2 antigen in human anterior nasal swabs. It is an ideal solution for point-of-care and decentralized testing to identify individuals with higher viral loads of SARS-CoV-2 that increase the likelihood of transmitting the infection to others. The test is wholly developed and manufactured in the UK utilizing accurate, flexible Affimer technology, and validated against emerging variants of SARS-CoV-2.
Mas detalles
Derecho de autor © 2000-2024 TradeMed.com. Todos los derechos reservados. | Términos y condiciones